Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Neuroone Medical Technologies (NMTC) Long-Term Debt Issuances (2016 - 2020)

Neuroone Medical Technologies' Long-Term Debt Issuances history spans 6 years, with the latest figure at $5.0 million for Q4 2020.

  • For Q4 2020, Long-Term Debt Issuances changed N/A year-over-year to $5.0 million; the TTM value through Dec 2020 reached $142427.0, changed N/A, while the annual FY2020 figure was $8.4 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $5.0 million in Q4 2020 per NMTC's latest filing, up from -$534201.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $5.0 million in Q4 2020 to a low of -$4.5 million in Q2 2017.
  • Average Long-Term Debt Issuances over 3 years is $23361.9, with a median of $8210.0 recorded in 2016.
  • Peak YoY movement for Long-Term Debt Issuances: skyrocketed 243.3% in 2016, then plummeted 55103.64% in 2017.
  • A 3-year view of Long-Term Debt Issuances shows it stood at $21106.0 in 2016, then plummeted by 2631.04% to -$534201.0 in 2017, then surged by 1035.98% to $5.0 million in 2020.
  • Per Business Quant, the three most recent readings for NMTC's Long-Term Debt Issuances are $5.0 million (Q4 2020), -$534201.0 (Q3 2017), and -$4.5 million (Q2 2017).